Literature DB >> 33347478

Performance of real-time PCR and immunofluorescence assay for diagnosis of Pneumocystis pneumonia in real-world clinical practice.

Darunee Chotiprasitsakul1, Pataraporn Pewloungsawat2, Chavachol Setthaudom3, Pitak Santanirand3, Prapaporn Pornsuriyasak4.   

Abstract

BACKGROUND: PCR is more sensitive than immunofluorescence assay (IFA) for detection of Pneumocystis jirovecii. However, PCR cannot always distinguish infection from colonization. This study aimed to compare the performance of real-time PCR and IFA for diagnosis of P. jirovecii pneumonia (PJP) in a real-world clinical setting.
METHODS: A retrospective cohort study was conducted at a 1,300-bed hospital between April 2017 and December 2018. Patients whose respiratory sample (bronchoalveolar lavage or sputum) were tested by both Pneumocystis PCR and IFA were included. Diagnosis of PJP was classified based on multicomponent criteria. Sensitivity, specificity, 95% confidence intervals (CI), and Cohen's kappa coefficient were calculated.
RESULTS: There were 222 eligible patients. The sensitivity and specificity of PCR was 91.9% (95% CI, 84.0%-96.7%) and 89.7% (95% CI, 83.3%-94.3%), respectively. The sensitivity and specificity of IFA was 7.0% (95% CI, 2.6%-14.6%) and 99.2% (95% CI, 95.6%-100.0%), respectively. The percent agreement between PCR and IFA was 56.7% (Cohen's kappa -0.02). Among discordant PCR-positive and IFA-negative samples, 78% were collected after PJP treatment. Clinical management would have changed in 14% of patients using diagnostic information, mainly based on PCR results.
CONCLUSIONS: PCR is highly sensitive compared with IFA for detection of PJP. Combining clinical, and radiological features with PCR is useful for diagnosis of PJP, particularly when respiratory specimens cannot be promptly collected before initiation of PJP treatment.

Entities:  

Mesh:

Year:  2020        PMID: 33347478      PMCID: PMC7751978          DOI: 10.1371/journal.pone.0244023

Source DB:  PubMed          Journal:  PLoS One        ISSN: 1932-6203            Impact factor:   3.240


  32 in total

1.  PCR diagnosis of Pneumocystis pneumonia: a bivariate meta-analysis.

Authors:  Yuan Lu; Guoya Ling; Chenyi Qiang; Qinshou Ming; Cong Wu; Ke Wang; Zouxiao Ying
Journal:  J Clin Microbiol       Date:  2011-10-19       Impact factor: 5.948

2.  Histopathology procedures: from tissue sampling to histopathological evaluation.

Authors:  Mohamed Slaoui; Laurence Fiette
Journal:  Methods Mol Biol       Date:  2011

Review 3.  Pneumocystis jirovecii pneumonia in non-HIV-infected patients: new risks and diagnostic tools.

Authors:  Alistair B Reid; Sharon C-A Chen; Leon J Worth
Journal:  Curr Opin Infect Dis       Date:  2011-12       Impact factor: 4.915

Review 4.  Opportunistic infections in patients with and patients without Acquired Immunodeficiency Syndrome.

Authors:  Kent A Sepkowitz
Journal:  Clin Infect Dis       Date:  2002-03-21       Impact factor: 9.079

5.  Persistence of trophozoites after successful treatment of Pneumocystis carinii pneumonia.

Authors:  W el-Sadr; G Sidhu
Journal:  Ann Intern Med       Date:  1986-12       Impact factor: 25.391

6.  Diagnosis of Pneumocystis carinii pneumonia: immunofluorescence staining, simple PCR or nPCR.

Authors:  M A Khan; N Farrag; P Butcher
Journal:  J Infect       Date:  1999-07       Impact factor: 6.072

Review 7.  Pneumocystis jirovecii pneumonia in non-HIV-infected patients in the era of novel immunosuppressive therapies.

Authors:  Sadatomo Tasaka; Hitoshi Tokuda
Journal:  J Infect Chemother       Date:  2012-08-06       Impact factor: 2.211

8.  Pneumocystis jirovecii (Pj) quantitative PCR to differentiate Pj pneumonia from Pj colonization in immunocompromised patients.

Authors:  M Maillet; D Maubon; J P Brion; P François; L Molina; J P Stahl; O Epaulard; A Bosseray; P Pavese
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2013-08-30       Impact factor: 3.267

9.  Detection of Pneumocystis DNA in samples from patients suspected of bacterial pneumonia--a case-control study.

Authors:  Jannik Helweg-Larsen; Jørgen Skov Jensen; Birthe Dohn; Thomas L Benfield; Bettina Lundgren
Journal:  BMC Infect Dis       Date:  2002-11-25       Impact factor: 3.090

Review 10.  Pneumocystis Pneumonia in Human Immunodeficiency Virus-infected Adults and Adolescents: Current Concepts and Future Directions.

Authors:  Sadatomo Tasaka
Journal:  Clin Med Insights Circ Respir Pulm Med       Date:  2015-08-12
View more
  3 in total

1.  Development and Evaluation of Rapid and Accurate CRISPR/Cas13-Based RNA Diagnostics for Pneumocystis jirovecii Pneumonia.

Authors:  Yangqing Zhan; Xiaoqing Gao; Shaoqiang Li; Yeqi Si; Yuanxiang Li; Xu Han; Wenjun Sun; Zhengtu Li; Feng Ye
Journal:  Front Cell Infect Microbiol       Date:  2022-06-15       Impact factor: 6.073

2.  [Adequacy to diagnostic recommendations in patients with Pneumocystis jirovecii pneumonia treated with intravenous pentamidine].

Authors:  L Cantarelli; F Gutiérrez Nicolás; G J Nazco Casariego; S García Gil
Journal:  Rev Esp Quimioter       Date:  2021-12-01       Impact factor: 1.553

3.  A Real-Time PCR Assay for Detection of Low Pneumocystis jirovecii Levels.

Authors:  Susana Ruiz-Ruiz; Carolina A Ponce; Nicole Pesantes; Rebeca Bustamante; Gianna Gatti; Viviana San Martin; Mireya Gutierrez; Pamela Bórquez; Sergio L Vargas; Fabien Magne; Enrique J Calderón; Vicente Pérez-Brocal; Andrés Moya
Journal:  Front Microbiol       Date:  2022-01-11       Impact factor: 5.640

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.